# Heuron Co., Ltd.

- Location (FDA's records): Incheon, KR
- FDA decisions: 5 (2021–2024): 5 510(k) clearances
- Product codes: LLZ (3), QAS (1), LNH (1)
- 510(k) review time since 2016: median 130 days, against 136 for FDA's reviews in the same codes and years (3 of 5 faster)
- Predicates its devices cite: 6 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Aidoc Medical, Ltd.: 1 (https://510kreport.com/company/aidoc-medical)
- Spintech, Inc.: 1 (https://510kreport.com/company/spintech)
- Siemens Medical Solutions USA, Inc.: 1 (https://510kreport.com/company/siemens-medical-solutions-usa)
- Mimvista Corp.: 1 (https://510kreport.com/company/mimvista)

## Firms that cite its devices most
- Neurophet., Inc.: 1 (https://510kreport.com/company/neurophet)

## Its most-cited devices
- K203142: Veuron-Brain-pAb (2021), cited by 2
- K213801: Veuron-Brain-pAb2 (2022), cited by 1

## Recent decisions
- K233247: Heuron ICH (May 15, 2024)
- K231642: Veuron-Brain-pAb3 (Oct 13, 2023)
- K203279: Veuron-Brain-mN1 (Jul 12, 2022)
- K213801: Veuron-Brain-pAb2 (Feb 4, 2022)
- K203142: Veuron-Brain-pAb (Jan 15, 2021)

Source page: https://510kreport.com/company/heuron